Santarus, Inc. is a specialty pharmaceutical company focused on acquiring, developing and commercializing products for the prevention & treatment of gastrointestinal diseases and disorders.

Stock Info

NASDAQ: SNTS
Current Price: 2.75
Change: -0.10

7/3/2009 7:57:09 PM EST
Quotes delayed 20 minutes.

Zegerid


June 26, 2009
Santarus Joins the Russell 3000 Index

June 23, 2009
Santarus Announces December 2009 Action Date for Schering-Plough''s OTC ZEGERID New Drug Application

June 9, 2009
Santarus Announces Schering-Plough Response Submission to FDA for OTC ZEGERID


Clinician Info
Patient Info

Careers Santarus is hiring skilled people like you. Join our team today!